Insight Molecular Diagnostics (IMDX) Receivables - Other (2017)

Insight Molecular Diagnostics (IMDX) posted Receivables - Other of $55000.0 for Q3 2017, up 66.67% sequentially from $33000.0 in Q2 2017.

Insight Molecular Diagnostics (IMDX) Receivables - Other (2017) Analysis & Trends

Insight Molecular Diagnostics has reported Receivables - Other for 1 years, with the latest figure at $55000.0 in Q3 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn
10	Insight Molecular Diagnostics	172.42 Mn	143.49 Mn	15,000.00

Download Data